Literature DB >> 28287789

Effects of adolescent exposure to methylmercury and d-amphetamine on reversal learning and an extradimensional shift in male mice.

Steven R Boomhower1, M Christopher Newland1.   

Abstract

Adolescence is associated with the continued maturation of dopamine neurotransmission and is implicated in the etiology of many psychiatric illnesses. Adolescent exposure to neurotoxicants that distort dopamine neurotransmission, such as methylmercury (MeHg), may modify the effects of chronic d-amphetamine (d-AMP) administration on reversal learning and attentional-set shifting. Male C57Bl/6n mice were randomly assigned to two MeHg-exposure groups (0 ppm and 3 ppm) and two d-AMP-exposure groups (saline and 1 mg/kg/day), producing four treatment groups (n = 10-12/group): control, MeHg, d-AMP, and MeHg + d-AMP. MeHg exposure (via drinking water) spanned postnatal days 21-59 (the murine adolescent period), and once daily intraperitoneal injections of d-AMP or saline spanned postnatal days 28-42. As adults, mice were trained on a spatial-discrimination-reversal (SDR) task in which the spatial location of a lever press predicted reinforcement. Following 2 SDRs, a visual-discrimination task (extradimensional shift) was instated in which the presence of a stimulus light above a lever predicted reinforcement. Responding was modeled using a logistic function, which estimated the rate (slope) of a behavioral transition and trials required to complete half a transition (half-max). MeHg, d-AMP, and MeHg + d-AMP exposure increased estimates of half-max on the second reversal. MeHg exposure increased half-max and decreased the slope term following the extradimensional shift, but these effects did not occur following MeHg + d-AMP exposure. MeHg + d-AMP exposure produced more perseverative errors and omissions following a reversal. Adolescent exposure to MeHg can modify the behavioral effects of chronic d-AMP administration. (PsycINFO Database Record (c) 2017 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28287789      PMCID: PMC5367946          DOI: 10.1037/pha0000107

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  49 in total

Review 1.  Comparative postnatal development of dopamine D(1), D(2) and D(4) receptors in rat forebrain.

Authors:  F I Tarazi; R J Baldessarini
Journal:  Int J Dev Neurosci       Date:  2000-02       Impact factor: 2.457

2.  Developmental exposure to methylmercury alters behavioral sensitivity to D-amphetamine and pentobarbital in adult rats.

Authors:  E B Rasmussen; M C Newland
Journal:  Neurotoxicol Teratol       Date:  2001 Jan-Feb       Impact factor: 3.763

Review 3.  Trajectories of brain development: point of vulnerability or window of opportunity?

Authors:  Susan L Andersen
Journal:  Neurosci Biobehav Rev       Date:  2003 Jan-Mar       Impact factor: 8.989

4.  Sexual dimorphism of brain developmental trajectories during childhood and adolescence.

Authors:  Rhoshel K Lenroot; Nitin Gogtay; Deanna K Greenstein; Elizabeth Molloy Wells; Gregory L Wallace; Liv S Clasen; Jonathan D Blumenthal; Jason Lerch; Alex P Zijdenbos; Alan C Evans; Paul M Thompson; Jay N Giedd
Journal:  Neuroimage       Date:  2007-04-06       Impact factor: 6.556

5.  Chronic cocaine exposure in adolescence: Effects on spatial discrimination reversal, delay discounting, and performance on fixed-ratio schedules in mice.

Authors:  Derek A Pope; Steven R Boomhower; Blake A Hutsell; Kathryn M Teixeira; M Christopher Newland
Journal:  Neurobiol Learn Mem       Date:  2016-02-08       Impact factor: 2.877

6.  Methylmercury impairs canonical dopamine metabolism in rat undifferentiated pheochromocytoma (PC12) cells by indirect inhibition of aldehyde dehydrogenase.

Authors:  Chelsea T Tiernan; Ethan A Edwin; Hae-Young Hawong; Mónica Ríos-Cabanillas; John L Goudreau; William D Atchison; Keith J Lookingland
Journal:  Toxicol Sci       Date:  2015-01-19       Impact factor: 4.849

Review 7.  Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation.

Authors:  Angie A Kehagia; Graham K Murray; Trevor W Robbins
Journal:  Curr Opin Neurobiol       Date:  2010-02-16       Impact factor: 6.627

8.  Adolescent methylmercury exposure affects choice and delay discounting in mice.

Authors:  Steven R Boomhower; M Christopher Newland
Journal:  Neurotoxicology       Date:  2016-09-24       Impact factor: 4.294

9.  Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice.

Authors:  Gregory B Bissonette; Gabriela J Martins; Theresa M Franz; Elizabeth S Harper; Geoffrey Schoenbaum; Elizabeth M Powell
Journal:  J Neurosci       Date:  2008-10-29       Impact factor: 6.167

Review 10.  The effects of environmental neurotoxicants on the dopaminergic system: A possible role in drug addiction.

Authors:  Douglas C Jones; Gary W Miller
Journal:  Biochem Pharmacol       Date:  2008-05-20       Impact factor: 5.858

View more
  10 in total

1.  d-Amphetamine and methylmercury exposure during adolescence alters sensitivity to monoamine uptake inhibitors in adult mice.

Authors:  Steven R Boomhower; M Christopher Newland
Journal:  Neurotoxicology       Date:  2019-02-12       Impact factor: 4.294

Review 2.  AMPed-up adolescents: The role of age in the abuse of amphetamines and its consequences on cognition and prefrontal cortex development.

Authors:  Sara R Westbrook; Lauren K Carrica; Asia Banks; Joshua M Gulley
Journal:  Pharmacol Biochem Behav       Date:  2020-08-20       Impact factor: 3.533

3.  The catecholaminergic neurotransmitter system in methylmercury-induced neurotoxicity.

Authors:  Marcelo Farina; Michael Aschner; João Batista Teixeira da Rocha
Journal:  Adv Neurotoxicol       Date:  2017-09-01

4.  Cognitive flexibility deficits in male mice exposed to neonatal hyperoxia followed by concentrated ambient ultrafine particles.

Authors:  Keith Morris-Schaffer; Marissa Sobolewski; Kevin Welle; Katherine Conrad; Min Yee; Michael A O'Reilly; Deborah A Cory-Slechta
Journal:  Neurotoxicol Teratol       Date:  2018-10-11       Impact factor: 3.763

5.  Endocrine active metals, prenatal stress and enhanced neurobehavioral disruption.

Authors:  Marissa Sobolewski; Katherine Conrad; Elena Marvin; Joshua L Allen; Deborah A Cory-Slechta
Journal:  Horm Behav       Date:  2018-02-01       Impact factor: 3.587

Review 6.  Peri-adolescent exposure to (meth)amphetamine in animal models.

Authors:  T J Phillips; S J Aldrich
Journal:  Int Rev Neurobiol       Date:  2021-08-20       Impact factor: 4.280

7.  Adolescent methylmercury exposure alters short-term remembering, but not sustained attention, in male Long-Evans rats.

Authors:  Dalisa R Kendricks; Steven R Boomhower; Megan A Arnold; Douglas J Glenn; M Christopher Newland
Journal:  Neurotoxicology       Date:  2020-03-19       Impact factor: 4.294

8.  D-serine reduces memory impairment and neuronal damage induced by chronic lead exposure.

Authors:  Jian-Zhu Bo; Ling Xue; Shuang Li; Jing-Wen Yin; Zheng-Yao Li; Xi Wang; Jun-Feng Wang; Yan-Shu Zhang
Journal:  Neural Regen Res       Date:  2021-05       Impact factor: 5.135

9.  Methylmercury, attention, and memory: baseline-dependent effects of adult d-amphetamine and marginal effects of adolescent methylmercury.

Authors:  Dalisa R Kendricks; Steven R Boomhower; M Christopher Newland
Journal:  Neurotoxicology       Date:  2020-07-26       Impact factor: 4.398

10.  Methylmercury exposure during prenatal and postnatal neurodevelopment promotes oxidative stress associated with motor and cognitive damages in rats: an environmental-experimental toxicology study.

Authors:  Beatriz Helena Fernandes Fagundes; Priscila Cunha Nascimento; Walessa Alana Bragança Aragão; Victória Santos Chemelo; Leonardo Oliveira Bittencourt; Luciana Eiró-Quirino; Marcia Cristina Freitas Silva; Marco Aurelio M Freire; Luanna Melo Pereira Fernandes; Cristiane do Socorro Ferraz Maia; Maria Elena Crespo-Lopez; Rafael Rodrigues Lima
Journal:  Toxicol Rep       Date:  2022-02-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.